Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Single-Use Systems and Chromatography Purification Techniques Improve Conjugate Vaccine Manufacturing

June 12, 2013

Conjugated vaccines are meeting the need for longer-lasting immune responses, but the production process is complex, and manufacturers are looking for simpler solutions.

EMA Revises Biosimilars Guideline

June 11, 2013

EMA's revised guideline on biosimilars containing biotechnology-derived proteins is published for public consultation.

Boehringer Ingelheim Plans Biopharmaceuticals Facility in China

June 10, 2013

Facility will use mammalian cell-culture technology and be ready for operations by 2016.

Novartis Receives FDA Warning Letter for cGMP Violations at Austrian Plant

June 05, 2013

The company is cited for using unapproved visual-inspection methods for finished parenteral drugs and conducting inadequate visual inspections.

Tablet-coating solution delivery system for enhanced coating applications

June 02, 2013

The Fluid Air Tablet Coating System consists of a modular air atomizing manifold, liquid-delivery skid, and Batch Architect process controls.

Using Model-Predictive Design in Solid-Dosage Manufacturing Processes

June 02, 2013

Models and modeling software gain a foothold in solid-dosage manufacturing process design.

Measuring Tablet Hardness: A Primer

June 02, 2013

Crushing, fracturing, and bending tests quantify hardness.

Understanding Biological Indicator Grow-Out Times—Part II

June 02, 2013

The authors report on the range and distribution of grow-out times for biological indicators exposed to sublethal sterilization processes.

GSK Acquires Vaccine Platform Tech Company Okairos

May 30, 2013

GSK expands its vaccines platform technology expertise by acquiring Okairos, a Swiss-based company.

Penn Pharma Opens Manufacturing Facility for Highly Potent Compounds

May 28, 2013

The South Wales, UK contained-manufacturing operation was built in less than a year using design-to-manufacture and modular approaches.